Evidence map›Paper›PMID 33722553›Full record

ArticleImmunology letters2021

Effect of Perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice.

Luisa Torres, Amie Redko, Candice Limper, Brian Imbiakha, Sue Chang, Avery August

Open access · greenAbstract read
In one paragraph

Article in Immunology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Developmental exposure to a PFAS mixture impairs the anamnestic response to influenza A virus infection in mice.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Guardians under Siege: Exploring Pollution's Effects on Human Immunity.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Quantifying the impact of PFOA exposure on B-cell development and antibody production.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  11. Article
  12. Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS).Environmental health : a global access science source · 2023
    Review
  13. Review
  14. Review
  15. Inactivation of common airborne antigens by perfluoroalkyl chemicals modulates early life allergic asthma.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Luisa TorresDepartment of Microbiology & Immunology, Cornell University, Ithaca, NY 14853, USA.
Amie RedkoDepartment of Microbiology & Immunology, Cornell University, Ithaca, NY 14853, USA.
Candice LimperDepartment of Microbiology & Immunology, Cornell University, Ithaca, NY 14853, USA.
Brian ImbiakhaDepartment of Microbiology & Immunology, Cornell University, Ithaca, NY 14853, USA.
Sue Chang3M Company, St. Paul, MN 55144, USA.
Avery AugustDepartment of Microbiology & Immunology, Cornell University, Ithaca, NY 14853, USA. Electronic address: averyaugust@cornell.edu.
Cornell University · US3M (United States) · US

Funding

Cornell Initiative for Maximizing Student DevelopmentR25GM125597 · NIGMS · CORNELL UNIVERSITY · PI AUGUST, AVERY · 2018 to 2022
$2.2M
NIGMS NIH HHS R25 GM125597
6 · The paper itself

Abstract

Perfluoroctanesulfonate (PFOS) belongs to a larger family of compounds known as Per- and polyfluoroalkyl substances (PFAS). The strength of the carbon-fluorine bond makes PFOS extremely resistant to environmental degradation. Due to its persistent nature, research has been directed to elucidating possible health effects of PFOS on humans and laboratory animals. Here we have explored the effects of PFOS exposure on immune development and function in mice. We exposed adult mice to 3 and 1.5 μg/kg/day of PFOS for 2 and 4 weeks, respectively, and examined the effects of PFOS exposure on populations of T cells, B cells, and granulocytes. These doses of PFOS resulted in serum levels of approximately 100 ng/mL with no weight loss during exposure. We find that PFOS does not affect T-cell development during this time. However, while PFOS exposure reduced immune cell populations in some organs, it also led to an increase in the numbers of cells in others, suggesting possible relocalization of cells. We also examined the effect of PFOS on the response to influenza virus infection. We find that exposure to PFOS at 1.5 μg/kg/day of PFOS for 4 weeks does not affect weight loss or survival, nor is viral clearance affected. Analysis of antibody and T cell specific antiviral responses indicate that at this concentration, PFOS does not suppress the immune cell development or antigen specific immune response.

Indexed as

Alkanesulfonic AcidsAnimalsAntibodies, ViralBiomarkersBone MarrowCell DifferentiationFemaleFluorocarbonsGranulocytesImmunologic FactorsImmunophenotypingInfluenza A virusLymphocytesMaleMiceOrgan SpecificityAlkanesulfonic AcidsAntibodies, ViralBiomarkersFluorocarbonsImmunologic Factorsperfluorooctane sulfonic acidImmune systemInfluenzaPFOS

Identifiers

PMID33722553
PMCPMC8577040
OpenAlexW3138924792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.